E6742 / Eisai 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
E6742 / Eisai
NCT05278663: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants

Completed
1/2
26
Japan
E6742, Placebo
Eisai Co., Ltd.
Lupus Erythematosus, Systemic
09/23
09/23

Download Options